ATE220860T1 - Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen - Google Patents

Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen

Info

Publication number
ATE220860T1
ATE220860T1 AT98946703T AT98946703T ATE220860T1 AT E220860 T1 ATE220860 T1 AT E220860T1 AT 98946703 T AT98946703 T AT 98946703T AT 98946703 T AT98946703 T AT 98946703T AT E220860 T1 ATE220860 T1 AT E220860T1
Authority
AT
Austria
Prior art keywords
alcohol
alcoholics
composition
withdrawal symptoms
prevention
Prior art date
Application number
AT98946703T
Other languages
German (de)
English (en)
Inventor
Aldo Fassi
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE220860T1 publication Critical patent/ATE220860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT98946703T 1997-10-03 1998-09-18 Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen ATE220860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (1)

Publication Number Publication Date
ATE220860T1 true ATE220860T1 (de) 2002-08-15

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946703T ATE220860T1 (de) 1997-10-03 1998-09-18 Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
EP0793962B1 (en) * 1996-03-04 1999-12-08 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Medicament containing a carnitine derivative for treating arteriosclerosis obliterans

Also Published As

Publication number Publication date
DE69806788T2 (de) 2003-04-03
SK283384B6 (sk) 2003-06-03
AU730740B2 (en) 2001-03-15
EA200000377A1 (ru) 2000-10-30
DE69806788D1 (de) 2002-08-29
EP1022960A1 (en) 2000-08-02
DK1022960T3 (da) 2002-11-04
PL189663B1 (pl) 2005-09-30
CN1276704A (zh) 2000-12-13
ITRM970594A1 (it) 1999-04-03
NO20001688D0 (no) 2000-03-31
BG64363B1 (bg) 2004-12-30
ES2180200T3 (es) 2003-02-01
CZ20001207A3 (cs) 2000-11-15
KR100530368B1 (ko) 2005-11-22
EA002177B1 (ru) 2002-02-28
JP2001518484A (ja) 2001-10-16
HUP0004336A2 (hu) 2001-05-28
EE200000235A (et) 2001-06-15
KR100560097B1 (ko) 2006-03-13
KR20010030928A (ko) 2001-04-16
UA66807C2 (uk) 2004-06-15
PL339621A1 (en) 2001-01-02
EP1022960B1 (en) 2002-07-24
WO1999017623A1 (en) 1999-04-15
PT1022960E (pt) 2002-12-31
AU9366098A (en) 1999-04-27
KR20050088499A (ko) 2005-09-06
CZ291801B6 (cs) 2003-05-14
CA2305598A1 (en) 1999-04-15
CN1092939C (zh) 2002-10-23
MXPA00003232A (es) 2004-03-10
IT1295408B1 (it) 1999-05-12
NO20001688L (no) 2000-06-02
US6255346B1 (en) 2001-07-03
HUP0004336A3 (en) 2001-07-30
NZ503663A (en) 2001-11-30
IS5416A (is) 2000-03-24
IS2234B (is) 2007-04-15
BR9812604A (pt) 2000-08-01
CA2305598C (en) 2007-11-20
HK1028714A1 (en) 2001-03-02
EE04036B1 (et) 2003-06-16
SK4762000A3 (en) 2000-10-09
BG104286A (en) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69806788D1 (de) Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
BR0211814A (pt) Formulação contendo (liso-)fosfatidilserina para a prevenção e tratamento de estados de tensão em animais de sangue quente
WO2001062290A3 (en) Methods and compositions for improving sleep
NO20015782L (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
IL122196A0 (en) Bicyclic-aromatic compounds
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
NO331190B1 (no) Anvendelse av ginkgo-komplekser og ikke-terapeutisk anvendelse av et diettsupplement av ginkgo-komplekser til forsterkning av kognitive funksjoner samt lettelse av mental tretthet
EP1393738A4 (en) MEDICINE AGAINST DIABETES
Klawans et al. Neuroleptic-induced tardive dyskinesias in nonpsychotic patients
WO2003013564A3 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
Dogra et al. Indigenous free radical scavenger MAK 4 and 5 in angina pectoris. Is it only a placebo?
PL371347A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
Cerrato Ginseng doesn't improve one's mood
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
AU2001278344A1 (en) Use of extracts from ginkgo biloba leaves for inducing dreams
Babich Derech HaTeva 2008-2009; v 13
ATE181239T1 (de) Verwendung von biertreberextrakt zur herstellung von oral zu verabreichenden zubereitungen
Dubin Dr. Kay Thompson BS, DDS “The Grande Dame”(Academia, Professionalism)
Services et al. National Research Service Awards. Final rule
Muster Congenital Heart Disease After Surgery: Benefits, Residua, Sequelae
Austin Vitamin C requirements
WO2002028430A3 (en) Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee